75 results
Page 4 of 4
F-1/A
EX-4.7
chpd4rmzpia
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
zc83b9
31 Jan 20
Registration statement (foreign)
12:00am
424B5
z66bf4cgs v6ws4
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
qjjqj1r8r5h6frtk0slr
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
4rk4u4yb
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
424B5
l5di77c
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
kd6rb189
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
68526q
24 Oct 18
Report of Foreign Private Issuer
6:45am
424B2
lbx460 lx
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
iwozt7dhz09 ul8ilqa
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
wle pnmb8
20 Jun 18
Shelf registration (foreign)
2:38pm
20-F
EX-4.3
xeyhgvvvcvb5oe64i
1 May 17
Annual report (foreign)
12:00am
20-F
by4308 yngqccbukz9i
1 May 17
Annual report (foreign)
12:00am